Summary

Kristin Klein is the pediatric infectious diseases clinical pharmacist specialist at the University of Michigan Hospitals and Health Centers (UMHHC) and a clinical associate professor at the College of Pharmacy.  She received her BS in pharmacy from Southwestern Oklahoma State University and her PharmD from the University of Oklahoma. She then completed a specialty residency in pediatric pharmacotherapy at the University of the Sciences in Philadelphia. Following her residency, Professor Klein joined the faculty of the University of Missouri-Kansas City, where she practiced in a neonatal intensive care unit until she joined the faculty at U-M. She is especially interested in training future practitioners. She spent four years serving on the UMHHC pharmacy residency advisory committee, including two years as the committee’s co-chair.  Professor Klein is currently the co-chair of the admissions committee, the co-advisor of the APhA-ASP chapter, and the coordinator of the residency teaching certificate program for UMHHC.

Research Interests

  • Antimicrobial use in pediatric patients

  • Antimicrobial stewardship in pediatric patients

Awards

  • 2016 Board Certified Pediatric Pharmacy Specialist, Board of Pharmacy Specialties
  • 2015 Professional Practice Award , Michigan Society of Health-Systems Pharmacists
  • 2015 Teaching Excellence Award, UM COP

Selected Publications

  • Klein K, Blackmer A, Diez H. The use of clinical debates as an active learning tool in two elective courses [abstract]. J Pediatr Pharmacol Ther 2013;18(2):159-60.

  • Weinber J, Klein K, Sheerer K, Loyson A. Respiratory viral infection in children: potential links between adenovirus and asthma [abstract]. J Pediatr Pharmacol Ther 2013;18(2):163.

  • Antworth A, Collins CD, Kunapali A, Klein K, Carver P, Gandhi J, Washer L, Nagel JL. Impact of an antimicrobial stewardship program comprehensive care bundle on the management of candidemia. Pharmacotherapy 2013;33(2):137-43.

  • Eyler RF, Klein KC, Mueller BA. The pharmacokinetics of oseltamivir and oseltamivir carboxylate in a critically ill pediatric patient receiving extracorporeal membrane oxygenation and continuous ven-venous hemodialysis. J Pediatr Pharmacol Ther 2012;17(2):173-6.

  • Blackwood RA, Klein KC, Micel L, Willers ML, Mody RJ, Teitelbaum DH, Cober MP. Ethanol locks for the treatment of fungal catheter infection. Pediatric Infectious Diseases Journal 2011;30(12):1105-7.